Measles Virus Destroys Immune System’s Memory of Past Infections
Two studies were conducted to determine whether measles infection causes long-term damage to immune memory.
Are We Finally Closing In On a Universal Influenza Vaccine?
For decades, scientists have discussed the concept of a “universal” flu vaccine that could provide broad protection against seasonal and pandemic influenza viruses, and we now have a number of promising vaccine candidates with a realistic chance to fulfill the dream.
Study Suggests MMR Vaccine May Be Linked with Fewer Deaths from COVID-19
Epidemiological data suggests populations with the highest measles-mumps-rubella (MMR) vaccination rates often have the fewest deaths from COVID-19.
The Critical Need for Vaccines and Higher Vaccine-Compliance Rates
Vaccines have historically eradicated deadly diseases, but a resistance among patients is a growing concern for public health.
In the Shadow of COVID-19, Will Other Vaccine Development Programs Be Left Behind?
As governments around the world ramp up COVID-19 prevention activities, are other diseases of international importance and their prevention programs suddenly on pause?
CDC Analyses Show Flu Vaccine Reduces Risk of Hospitalization in Children and Death in Adults
Two analyses by the Centers for Disease Control and Prevention (CDC) show the influenza (flu) vaccine can reduce the likelihood of hospitalization in children and death in adults.
Trivalent HBV Vaccine Superior in Efficacy in Adults 45 Years and Older
A Phase III study has found a trivalent hepatitis B virus (HBV) vaccine demonstrated superiority in adults 45 years and older and noninferior in adults older than 18 years compared with a monovalent vaccine.
Flu Vaccine May Reduce Risk of Heart Attack and Stroke in Hypertensive Individuals
A new study shows cardiovascular outcomes may improve in individuals with hypertension if they receive the influenza (flu) vaccine during the flu season.
Skin Patch Shows Promise for Delivery of Influenza Vaccine
Researchers at the University of Rochester Medical Center in New York City have developed a new type of skin patch that could replace needles as a method to deliver the influenza (flu) vaccine.
NIAID Awards $30 Million to Develop Tuberculosis Vaccine
The awards establish and provide up to seven years of support for three Immune Mechanisms of Protection Against Mycobacterium Tuberculosis (IMPAc-TB) Centers to elucidate the immune responses needed to protect against Mtb infection.
